240 results
The Evidence for Aspirin - Visual Abstract

Three new aspirin trials in three different populations: 
 -
The Evidence for Aspirin ... Abstract Three new aspirin ... Moderate Risk (ASCVD ... mortality #Aspirin
Salicylate Poisoning - Diagnosis and Management

#Salicylate #Poisoning #Toxicology #Diagnosis #Management #Aspirin #Treatment
Salicylate #Poisoning #Toxicology ... Diagnosis #Management #Aspirin
Reye Syndrome 
Progressive encephalopathy with hepatic dysfunction 

#Reyes #Syndrome #Toxicology #Peds #Pediatrics #aspirin #salicylate
Reyes #Syndrome #Toxicology ... Peds #Pediatrics #aspirin
Acute Salicylate Toxicity - Diagnosis and Management
#Diagnosis #Management #Toxicology #Salicylate #Aspirin #Toxicity #ALiEM
Diagnosis #Management #Toxicology ... #Salicylate #Aspirin
Toxicologic Assessment of Cyanosis (Goldfrank’s Toxicology)
#Diagnosis #Management #Toxicology #Cyanosis #Methemoglobinemia #Assessment #Algorithm
Toxicologic Assessment ... Cyanosis (Goldfrank’s Toxicology ... Diagnosis #Management #Toxicology
Alkalinization shifts equilibrium toward the plasma and urine and away from the tissues.

#Management #Toxicology #Salicylate #Aspirin
#Management #Toxicology ... #Salicylate #Aspirin
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
- Established ASCVD ... Without established ASCVD
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
events in T2DM + ASCVD ... events in T2DM + ASCVD ... or ASCVD risk; ... MACE, in T2DM + ASCVD ... or ASCVD risk.
Mesenteric Ischemia - Differential Diagnostic Schema
Chronic: ASCVD, Venous, Vasculitides 5% (PAN, [E]GPA, IgA, MPA)
Acute
 - Venous
Schema Chronic: ASCVD ... hypo-/akinesis), ASCVD ... failure, Dissection, ASCVD
ABCDE of Primary ASCVD Prevention: Lifestyle Changes and Team-Based Care - Checklist
A – Antiplatelet Therapy
B –
ABCDE of Primary ASCVD ... #PrimaryCare #ASCVD